PDX Core
PDX Core
批准号:
10733194
负责人:
Meenhard F Herlyn
金额:
$11.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-01 至 2028-08-31
关键词:
3-DimensionalBiologicalBiological AssayBiological ModelsCell AggregationCell LineCellsCellular biologyClinicalCollaborationsCollagenDNADNA sequencingDataData Storage and RetrievalDatabasesDevelopmentDimensionsDiseaseEnsureFreezingFutureGeneticGenetic FingerprintingsGrowthGuidelinesHumanImmunodeficient MouseIn VitroLaboratoriesLesionMelanoma CellMethodologyMethodsModelingMolecularMolecular AbnormalityMolecular ProfilingMonitorMusNeoplasm MetastasisOrganoidsPatientsPilot ProjectsPre-Clinical ModelQuality ControlReproducibilityResearchResearch PersonnelResearch Project GrantsResourcesScientistServicesSkinSpecimenTestingTrainingWorkcell bankdata sharingexomeexperimental studyin vitro Modelin vivo Modelinvestigator trainingmelanomamemberneoplastic cellnovel therapeuticspathogenpatient derived xenograft modelpre-clinicalpreclinical studyprogramsprotein expressionscreeningsubcutaneoussuccessthree-dimensional modelingtooltranscriptome sequencingtumortumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary – PDX Core B
The PDX Core provides major resources to the program investigators, including melanoma PDX, melanoma
cell lines and 3D models such as organoids, spheres, and spheroids, to explore new therapies. Our melanoma
PDX pre-clinical platform encompasses >500 different tumors representing all clinical, biologic, and genetic
groups of the disease. The primary focus of the PDX Core is to establish, bank and distribuite new PDX and
PDX-derived models. The PDX Core also coordinates the characterization the pre-clinical melanoma models at
at the biological (e.g. growth and metastasis) and molecular (e.g. DNA- and RNA-sequencing, and protein
expression) levels. The core maintains a master cell bank, conducts quality control of specimens and derived
models and monitors for mouse pathogens. The core is also the central facilitator for exchanging PDX within
the PDXNet and coordinates collaborations with other investigators within the program, the overall PDXNet
and outside scientists. The core coordinates data storage, data sharing and distribution to other investigators
within the program.
The PDX Core is available to train investigators of the program in all biological assays and models. Overall,
this core will provide efficient and high-quality service to all investigators within this PDTC. The PDX Core is
also available to assist investigators withinPDXNet and collaborators as requested.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gamma delta T cell based melanoma therapies
-
批准号:10365762
-
项目类别:
-
资助金额:$66.67万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10381269
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Administrative Core
-
批准号:10268741
-
项目类别:
-
资助金额:$21.79万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Neoadjuvant immunotherapy approaches to early stage melanoma
-
批准号:10480856
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Developmental Research Program
-
批准号:10480863
-
项目类别:
-
资助金额:$8.84万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Administrative Core
-
批准号:10480830
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Gamma delta T cell based melanoma therapies
-
批准号:10540374
-
项目类别:
-
资助金额:$63.27万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Neoadjuvant immunotherapy approaches to early stage melanoma
-
批准号:10268746
-
项目类别:
-
资助金额:$46.67万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Explore Gamma delta T cell-based glioblastoma therapies
-
批准号:10829731
-
项目类别:
-
资助金额:$15.88万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Developmental Research Program
-
批准号:10268747
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2021
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10307107
-
项目类别:
-
资助金额:$49.38万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:9887923
-
项目类别:
-
资助金额:$52.28万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10737745
-
项目类别:
-
资助金额:$11.67万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10524132
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
-
批准号:10532797
-
项目类别:
-
资助金额:$49.38万
-
财政年份:2019
-
负责人:Meenhard F Herlyn
-
依托单位:
PDX Core
-
批准号:10681841
-
项目类别:
-
资助金额:$9.41万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
Research Project 1 - Targeting the MAPK and PI3K pathways in melanoma PDX
-
批准号:10681844
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
Administrative Core
-
批准号:10681840
-
项目类别:
-
资助金额:$7.04万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
Pilot-Trans Network Core
-
批准号:10733198
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
Administrative Core
-
批准号:10494403
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2017
-
负责人:Meenhard F Herlyn
-
依托单位:
海外基金